FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Thomas

Research Profile

Chemicals & Drugs

Concepts & Ideas

Occupations

Co-author Network

Publications

TOP 3
Malcolm Anderson; David M Andrews; Andy J Barker; Claire A Brassington; Jason Breed; Kate F Byth; Janet D Culshaw; M Raymond V Finlay; Eric Fisher; Helen H J McMiken; Clive P Green; Dave W Heaton; Ian A Nash; Nicholas J Newcombe; Sandra E Oakes; Richard A Pauptit; Andrew Roberts; Judith J Stanway; Andrew P Thomas; Julie A Tucker; Mike Walker; Hazel M Weir
Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitors.
Kate F Byth; Catherine Geh; Cheryl L Forder; Sandra E Oakes; Andrew P Thomas
The cellular phenotype of AZ703, a novel selective imidazo[1,2-a]pyridine cyclin-dependent kinase inhibitor.
Kate F Byth; Nicola Cooper; Janet D Culshaw; David W Heaton; Sandra E Oakes; Claire A Minshull; Richard A Norman; Richard A Pauptit; Julie A Tucker; Jason Breed; Andrew D Pannifer; Siân Rowsell; Judith J Stanway; Anna L Valentine; Andrew P Thomas
Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Thomas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Malcolm Anderson; David M Andrews; Andy J Barker; Claire A Brassington; Jason Breed; Kate F Byth; Janet D Culshaw; M Raymond V Finlay; Eric Fisher; Helen H J McMiken; Clive P Green; Dave W Heaton; Ian A Nash; Nicholas J Newcombe; Sandra E Oakes; Richard A Pauptit; Andrew Roberts; Judith J Stanway; Andrew P Thomas; Julie A Tucker; Mike Walker; Hazel M Weir
Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitors.
Bioorganic & medicinal chemistry letters 2008;18(20):5487-92.
2006: Kate F Byth; Catherine Geh; Cheryl L Forder; Sandra E Oakes; Andrew P Thomas
The cellular phenotype of AZ703, a novel selective imidazo[1,2-a]pyridine cyclin-dependent kinase inhibitor.
Molecular cancer therapeutics 2006;5(3):655-64.
2004: Kate F Byth; Nicola Cooper; Janet D Culshaw; David W Heaton; Sandra E Oakes; Claire A Minshull; Richard A Norman; Richard A Pauptit; Julie A Tucker; Jason Breed; Andrew D Pannifer; Siân Rowsell; Judith J Stanway; Anna L Valentine; Andrew P Thomas
Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors.
Bioorganic & medicinal chemistry letters 2004;14(9):2249-52.
2004: Kate F Byth; Janet D Culshaw; Stephen Green; Sandra E Oakes; Andrew P Thomas
Imidazo[1,2-a]pyridines. Part 2: SAR and optimisation of a potent and selective class of cyclin-dependent kinase inhibitors.
Bioorganic & medicinal chemistry letters 2004;14(9):2245-8.
2003: Malcolm Anderson; John F Beattie; Gloria A Breault; Jason Breed; Kate F Byth; Janet D Culshaw; Rebecca P A Ellston; Stephen Green; Claire A Minshull; Richard A Norman; Richard A Pauptit; Judith J Stanway; Andrew P Thomas; Philip Jewsbury
Imidazo[1,2-a]pyridines: a potent and selective class of cyclin-dependent kinase inhibitors identified through structure-based hybridisation.
Bioorganic & medicinal chemistry letters 2003;13(18):3021-6.